Skip to main content
Uncategorized

IRB Barcelona coordinates a European consortium to find pre-drugs against diabetes and obesity

By 13 de May de 2009November 18th, 2020No Comments
< Back to news
 13.05.2009

IRB Barcelona coordinates a European consortium to find pre-drugs against diabetes and obesity

Antonio Zorzano, researcher at the Institute for Research in Biomedicine (IRB Barcelona) and professor of Molecular Biology at the University of Barcelona, coordinates a European consortium to find new compounds for the treatment of diabetes and obesity. The project, entitled DIOMED (acronym of: Diabetes, Obesity and Medicine), is part of the EU's SUDOE call, aimed to further the technological development of southern Europe.


The new consortium involves two technology clusters with experience in technology transfer –the Barcelona Science Park (acronym in Catalan PCB), which hosts IRB Barcelona, and the BIOCANT Park in Portugal–, plus four groups working in basic research. The DIOMED project will last three years, until 2011, and has been awarded funds amounting to more than one million Euros.

Fore more information